Invesco Ltd. - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 53 filers reported holding CYTOSORBENTS CORP in Q3 2023. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q1 2022$44,000
-26.7%
13,909
-2.3%
0.00%
Q4 2021$60,000
-49.6%
14,233
-2.8%
0.00%
Q3 2021$119,000
+43.4%
14,645
+32.6%
0.00%
Q2 2021$83,000
-39.0%
11,044
-29.1%
0.00%
Q1 2021$136,000
-35.5%
15,577
-44.0%
0.00%
Q1 2019$211,000
-18.5%
27,819
-13.4%
0.00%
Q4 2018$259,000
-91.0%
32,110
-85.5%
0.00%
-100.0%
Q3 2018$2,862,000
+710.8%
221,897
+617.5%
0.00%
Q2 2018$353,00030,9280.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 692,738$5,524,0002.01%
Skylands Capital, LLC 1,421,700$11,345,0001.89%
SECTORAL ASSET MANAGEMENT INC 1,629,989$12,999,0001.12%
Winning Points Advisors, LLC 286,200$1,142,990,0000.97%
Redmile Group, LLC 2,101,131$16,757,0000.31%
Granahan Investment Management 632,035$5,040,0000.17%
Avenir Corp 190,240$1,517,0000.16%
Seelaus Asset Management LLC 20,000$160,0000.13%
Olympiad Research LP 17,816$142,0000.07%
HighMark Wealth Management LLC 10,000$80,0000.07%
View complete list of CYTOSORBENTS CORP shareholders